Sesen Bio jumps after starting strategic review of business

Carisma Therapeutics

03/05/2022 16:54

** Sesen Bio Inc's shares  SESN.O  up 15% at $0.45 in
morning trade
    ** Starts process to review strategic alternatives, which
may include sale of company, merger, acquisition or other
business combination  urn:newsml:reuters.com:*:nBw161YnMa
    ** Co has been under pressure since August when the FDA
declined to approve its lead drug candidate for bladder cancer
 urn:newsml:reuters.com:*:nL4N2PK3Q4  urn:newsml:reuters.com:*:nL4N2Q42P5  urn:newsml:reuters.com:*:nL4N2SU370
    ** Despite session's gain, stock down 45% YTD

 (Reporting by Leroy Leo in Bengaluru)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))